NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain

NRx has Licensed US Patent 8,653,120 for use of D-Cycloserine to treat Chronic Pain Dr. Vania Apkarian, a world leader in pain and D-Cycloserine (DCS) research, has joined the NRx Scientific Advisory Board RADNOR, Pa., Aug. 7, 2023 -- (Healthcare Sal... Biopharmaceuticals, Licensing NRx Pharmaceuticals, D-Cycloserine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news